Author

Zoë Wallace

Observed names: Wallace, Zoë R., Zoe Wallace, Zoë R. Wallace

Institution: Immunocore (United Kingdom)

Observed institutions: Erasmus MC, University of Oxford, Immunocore (United Kingdom)

ORCID: 0000-0001-5320-4718

Observed ORCID: 0000-0001-5320-4718

OpenAlex ID: A5082554111

Rational Zika vaccine design via the modulation of antigen membrane anchors in chimpanzee adenoviral vectors

2018 · César López-Camacho, Peter Abbink, et al. · Nature Communications · 88

Immune‐Mobilizing Monoclonal T Cell Receptors Mediate Specific and Rapid Elimination of Hepatitis B–Infected Cells

2020 · Joannah R. Fergusson, Zoë Wallace, et al. · Hepatology · 52

Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors

2016 · Hongbing Yang, Sandrine Buisson, et al. · Molecular Therapy · 49

Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction

2018 · Hongbing Yang, Zoë Wallace, et al. · Frontiers in Immunology · 34

Instability of the HLA-E peptidome of HIV presents a major barrier to therapeutic targeting

2024 · Zoë Wallace, Tiaan Heunis, et al. · Molecular Therapy · 17

Combination strategies to durably suppress HIV-1: Soluble T cell receptors

2022 · Zoë Wallace, Praveen K. Singh, et al. · Journal of Virus Eradication · 9

Exposure to zidovudine adversely affects mitochondrial turnover in primary T cells

2016 · Zoë R. Wallace, Sharon Sanderson, et al. · Antiviral Research · 8

Immune mobilising T cell receptors redirect polyclonal CD8+ T cells in chronic HIV infection to form immunological synapses

2022 · Zoë Wallace, Jakub Kopycinski, et al. · Scientific Reports · 6

Safety and biologic activity of a bispecific T cell receptor targeting HIV Gag in males living with HIV: a first-in-human trial

2026 · Linos Vandekerckhove, Julie Fox, et al. · Nature Communications · 5

Novel ImmTAV molecules for the treatment of HBV

2018 · T Laftsoglou, M Vranas, et al. · Journal of Viral Hepatitis · 1

Engineered affinity-enhanced immune-mobilising monoclonal T cell receptors (ImmTAVs) for HIV cure

2017 · Zoë Wallace, Hongli Yang, et al. · HIV Medicine · 1

HBV specific ImmTAV induce a broad immune response enabling the elimination of HBV positive cells

2020 · Sarah Leonard, Rachel Paterson, et al. · Journal of Hepatology

Immtav, a novel immunotherapy approach to eliminate hepatitis B virus

2020 · Ruth Martinez Hague, Dominic Hine, et al. · Journal of Hepatology

Application of engineered T cell receptors to investigate the failure of cytotoxic T lymphocytes to eliminate the HIV reservoir

2017 · Wallace, Zoë R. · Oxford University Research Archive (ORA) (University of Oxford)

Engineered Gag-specific T-cell Receptors Redirect Polyclonal CD8 + T-cells to Clear HIV-1-infected CD4 + T-cells from ART-treated Patients

2014 · Hongbing Yang, Sandrine Buisson, et al. · AIDS Research and Human Retroviruses

Works count: 15

Citation count: 270

H-index: 7

I10-index: 5